Mercury Laboratories Ltd

Tue 22/09/2026,16:1:0 | BSE : MERCURYLAB

₹817.000.45 (0.06%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 805.00

Previous Close

₹ 816.55

Volume

61

Mkt Cap ( ₹ Cr)

₹ 98.04

High

₹ 830.00

Low

₹ 802.00

52 Week High

₹ 942.90

52 Week Low

₹ 620.55

Book Value Per Share

₹ 486.45

Dividend Yield

₹ 0.42

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Mercury Laboratories Ltd

Your Vote -

Buy

33.33%

Hold

33.33%

Sell

33.33%

33.33%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Mercury Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    3 Sep 2026, 6:19PM Intimation for appointment of Manager HR as senior Management is attched
  • Mercury Laboratories - Reg. 34 (1) Annual Report.

    1 Sep 2026, 5:44PM Please find enclosed herewith a copy of 45th Annual Report of the Company for the Financial Year ended March 31, 2026.
  • Mercury Laboratories - Submission Of Notice Of The 45Th Annual General Meeting Of The Company

    1 Sep 2026, 5:36PM Please find enclosed herewith a copy of 45th AGM notice of the Company scheduled to be held on 28/09/2026 at 11.30 AM IST
  • Mercury Laboratories has declared 35% Final dividend for the financial year March 2026

    23 Aug 2026, 6:20PM Mercury Laboratories Ltd. on Friday, 29 May 2026, has announced Final dividend of 35 percent on Equity Share, to its shareholders holding shares on th
  • Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    21 Aug 2026, 2:32PM Intimation regarding appointment of Mr. Sunil Sharma and resignation of Ms. Seema Salvi as HOD injectable
  • Mercury Laboratories - Communication To Shareholders - Intimation On Tax Deduction On Dividend

    20 Aug 2026, 5:58PM Communication to Shareholders on TDS on the dividend for the FY 25-26 is attached
  • Mercury Laboratories - Unaudited Financial Results For The Quarter Ended On June 30, 2026

    25 Jul 2026, 12:21PM Unaudited Financial results for the quarter ended on June 30, 2026 is attched
  • Mercury Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Held On July 25, 2026

    25 Jul 2026, 12:16PM Outcome of meeting for approval of the unaudited financial statement for the quarter ended on June 30, 2026 is attched
  • Mercury Laboratories - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended On June

    16 Jul 2026, 5:38PM Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider
  • Mercury Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    14 Jul 2026, 1:01PM As of June 2026, 73.66% is owned by Indian Promoters and 26.34% by Public. <p align=justify> Top five Promoters holding highest number of shares of Me
  • Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Jul 2026, 5:53PM Certificate of Compliance under Reg 74(5) of SEBI(DP) Reg, 2018 for the quarter ended on June 30, 2026 is attached
  • Mercury Laboratories - Announcement under Regulation 30 (LODR)-Credit Rating

    1 Jul 2026, 4:26PM Intimation regarding Credit Rating on Fixed deposit is attached

Key fundamentals

Evaluate the intrinsic value of Mercury Laboratories Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 65.4851 57.6628 56.3341 50.9931 45.4082
Liabilities 65.4851 57.6628 56.3341 50.9931 45.4082
Equity 1.2 1.2 1.2 1.2 1.2
Gross Profit 9.0414 7.0165 9.0303 8.5705 7.1145
Net Profit 4.834 3.1449 5.6542 5.5788 3.6862
Cash From Operating Activities 4.2398 4.0011 8.225 2.4524 5.1505
NPM(%) 6.36 4.18 7.48 7.4 6.36
Revenue 75.9367 75.1012 75.559 75.3337 57.9238
Expenses 66.8953 68.0847 66.5287 66.7632 50.8093
ROE(%) 8.28 5.38 9.68 9.55 6.31

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Mercury Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 847.00 0.83 21.47 466.02 -26.19 0.59
Lotus Eye Hospital and Institute Ltd 116.25 0.65 1642.43 1698.12 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 13.98 0.79 0.00 3525.86 -39.50 0.00
Astec Lifesciences Ltd 793.90 10.30 0.00 1819.45 -363.14 0.00

Company Info

The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. Welcome to Mercury Laboratories Limited. For more than 6 decades, we have been at the forefront of formulating, developing, marketing and distributing safe, innovative and cost- effective pharmaceuticals that help to improve the quality of life of patients. In so doing, we have delivered long-term, profitable returns to our investors, value to our partners and rewarding career to our employees. We are mainly dedicated to Mother & Child Healthcare. We have state of the art modern manufacturing facility spread in 435600 sq. ft. (40,468 sq. mt.) of land. The technology delivers products like of international standards and specifications. The expertise of skilled and professional manpower ensures that the customers get new products & packaging as per need of their country and regulatory standards. At present, the facilities are up to the mark of the international standards and quality. We have separate manufacturing units for Tablets, Oral Liquids and Injections, small volume Parenteral & Ophthalmic Preparation. Mercury's manufacturing facilities is designed, equipped and operated to deliver high quality products within defined cost and delivery schedules. These manufacturing facilities have flexibility to operate in various dosage forms and wide range of batch sizes. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited.2015-Mercury Laboratories is been listed in BSE.

The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. Welcome to Mercury Laboratories Limited. For more than 6 decades, we have been at the forefront of formulating, developing, marketing and distributing safe, innovative and cost- effective pharmaceuticals that help to improve the quality of life of patients. In so doing, we have delivered long-term, profitable returns to our investors, value to our partners and rewarding career to our employees. We are mainly dedicated to Mother & Child Healthcare. We have state of the art modern manufacturing facility spread in 435600 sq. ft. (40,468 sq. mt.) of land. The technology delivers products like of international standards and specifications. The expertise of skilled and professional manpower ensures that the customers get new products & packaging as per need of their country and regulatory standards. At present, the facilities are up to the mark of the international standards and quality. We have separate manufacturing units for Tablets, Oral Liquids and Injections, small volume Parenteral & Ophthalmic Preparation. Mercury's manufacturing facilities is designed, equipped and operated to deliver high quality products within defined cost and delivery schedules. These manufacturing facilities have flexibility to operate in various dosage forms and wide range of batch sizes. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited.2015-Mercury Laboratories is been listed in BSE.

Parent Organisation

Mercury Laboratories Ltd.

Founded

12/02/1982

Managing Director

Mr.Rajendra R Shah

NSE Symbol

FAQ